The distinctive organization of enzymes in early breast ductal cancer can be used to correctly predict recurrences in 91% of cases, with 4% false negatives, a new study has found. The diagnostic tool may assist with the early identification of patients at high risk of cancer recurrence while reducing overdiagnosis and treatment of low-risk patients. The study, “Spatial locations of certain enzymes and transporters within preinvasive ductal epithelial cells predict human breast cancer recurrences,” was…
You must be logged in to read/download the full post.
The post Computer Model Uses Enzyme Organization to Predict Early Breast Cancer Recurrence appeared first on BioNewsFeeds.